54gene is an African genomics research, services and development company addressing the need to include under-represented African genomic data in research, which could lead to medical breakthroughs and new healthcare solutions worldwide. Through its research collaborations and commercial partnerships, it will enable the study of African genetics to learn the underlying genetic drivers of disease affecting everyone globally. Additionally, 54gene strives to understand the genetic impact on disease penetrance and risk in Africans, with a goal of developing better diagnostic and risk assessment tests to inform a more targeted approach to healthcare.

Abonnez-vous aux mises à jour

Une mise à jour hebdomadaire de ce qui est à l'Agenda mondial

© 2022 World Economic Forum

Politique de confidentialité et conditions d’utilisation du service